Alternatives to C2i Genomics

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Natera is a global leader in cell-free DNA testing, providing genetic testing services for reproductive health, oncology, and organ transplantation.

Nucleix is a liquid biopsy company developing early cancer detection solutions using methylation analysis.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

A molecular diagnostics company focused on integrating genomics with personalized therapeutic approaches for cancer.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

MeMed develops and commercializes host immune response diagnostic solutions to address complex clinical dilemmas and improve patient outcomes.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

AI-powered blood analysis for precise substance tracing and classification in healthcare and research.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Provides AI-powered data analysis solutions for molecular diagnostics and research, streamlining qPCR data interpretation.

Advanced diagnostics for preventative health and personalized cancer treatment using AI and genomics.

AI-powered blood test for early cancer detection and subtyping.

AI-driven diagnostics that convert medical images into actionable genomic insights for faster cancer treatment decisions.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

AI-powered multi-omics platform for early breast cancer detection and risk prediction.

Variantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.

AI-powered spatial biology platform for precision medicine and drug development.

Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.